Get started

Chart Patterns

WIFUSDT: Long-Term Bullish SetupI spend time researching and finding the best entries and setups, so make sure to boost and follow for more. DogWiFiHat ( KUCOIN:WIFUSDT ): Long-Term Bullish Setup for a Multi-Month Hold Trade Setup: - Entry Price: $2.0682 (Activated) - Stop-Loss: $0.2580 - Take-Profit Targets: - TP1: $5.6605 - TP2: $10.2864 Fundamental Analysis: DogWiFiHat ( KUCOIN:WIFUSDT ) is an innovative cryptocurrency project aimed at merging decentralized connectivity solutions with meme-inspired community engagement. With its growing adoption and strategic partnerships in the tech sector, $ KUCOIN:WIFUSDT is creating a niche within the blockchain space. The anticipated market bullishness by May adds further potential for a strong rally. Recent community-driven campaigns and developments in the ecosystem are expected to enhance its visibility and attract more long-term investors. Technical Analysis (Daily Timeframe): - Current Price: $2.0820 - Moving Averages: - 50-Day SMA: $1.8000 - 200-Day SMA: $1.5000 - Relative Strength Index (RSI): Currently at 63, indicating bullish momentum. - Support and Resistance Levels: - Support: $1.9000 - Resistance: $2.5000 KUCOIN:WIFUSDT has broken out of a consolidation phase, supported by strong buying volume. A confirmed breakout above $2.50 will likely drive the price toward TP1 and eventually TP2 as the market enters a more bullish phase. Market Sentiment: DogWiFiHat is riding the wave of increasing interest in meme-inspired cryptocurrencies with real-world use cases. With the broader market sentiment turning positive, KUCOIN:WIFUSDT is poised for significant upside potential. Risk Management: The stop-loss at $0.2580 provides strong downside protection, while the take-profit targets offer excellent reward potential. TP1 represents a 173% return, with TP2 providing a potential 397% gain for long-term holders. Key Takeaways: - KUCOIN:WIFUSDT combines meme culture with real-world utility, making it a unique play in the crypto space. - The trade setup offers significant upside potential, aligning with market-wide bullish expectations through May. - Strict adherence to stop-loss and take-profit levels is crucial for managing risk. When the Market’s Call, We Stand Tall. Bull or Bear, We’ll Brave It All! *Disclaimer: This analysis is for informational purposes only and does not constitute financial advice. Traders should conduct their own due diligence before making investment decisions.*
Long
by SiriusTrading
BTC.D ChartAs i mentioned in my previous analysis i expected BTC.D to have it's pull back to the inverse cup & handle pattern and midline of it's channel and we got a beautiful red inverse hammer from the resistance zone. Im expecting BTC.D to continue it's path to the lower numbers which will give alt coins some room to grow and a future alt season. Market might give a bit more correction due to other charts which you can read on my profile, but don't get shaken out and buy the dips and you'll thank me later. The Giga cycle is upon us. DYOR Goodluck
CRYPTOCAP:BTC.D
by Arisha_Najjaran
1
SOLUSDT Price Action Analysis - Bullish Breakout OpportunityThe 1-hour chart of SOLUSDT shows promising signs of a potential bullish breakout. The price has been moving in a descending channel, but it is now testing the downward trendline (blue). A confirmed breakout above this line could signal the start of a strong upward move. Bullish Scenario: If the price breaks and stabilizes above the $187-$190 range, it would confirm the bullish reversal. The first target is $202, a key resistance level based on previous price action. If the bullish momentum continues, the next target is set at $213, aligning with a critical resistance zone and a longer-term trendline. Trading Strategy: Focus on entering a long position after the price breaks and holds above the $187 level. First target: $202. Second target: $213. Stop-loss: Below $180 to limit potential downside risk. The chart indicates strong potential for upward movement if the breakout is confirmed, making this a favorable opportunity for long positions. Proper risk management is essential to handle any unexpected market reversals.
Long
by mohammad_crypt1372
EUR/USD 30-Minute Chart AnalysisEUR/USD 30-Minute Chart Analysis The EUR/USD pair is currently trading within a well-defined upward channel, showing bullish momentum. It recently moved from the support level around 1.0330 to test resistance at approximately 1.0457, with the current price around 1.0429. Key levels to watch include: Resistance: Immediate resistance at 1.0457 and potential higher resistance near 1.0475. Support: Initial support at approximately 1.0384 and stronger support near the previous low at 1.0330. Traders should watch for potential reversal signals from RSI and MACD, as well as volume trends that can confirm market sentiment. Overall, the pair presents opportunities for both long and short positions depending on price action dynamics. Note: This analysis is for educational purposes and not trading advice. Consider market conditions and strategies. Please do not forget the like button, Share it with your friends,thanks, and Trade safe.
by David_Josh_Trader
XAUUSD 99% confirm Gold (XAU/USD) is trading with a moderate positive tone on Friday following the sharp sell-off earlier this week. Cooler-than-expected US Personal Consumption Expenditures (PCE) Price Index data on Friday has increased selling pressure on the US Dollar, although the precious metal is struggling to put a significant distance from the one-month lows hit this weekPCE Inflation has increased 0.1% in November, against expectations of a 0.2% increment. The yearly rate accelerated to 2.4% from the previous month's 2.3% reading, still below the 2.5% anticipated by the market consensus. Likewise, the Core PCE eased to 0.1% from 0.3% in October while the yearly inflation remained steady at 2,8% against market expectations of an uptick to 2.9%from heavily oversold levels. The broader trend, however, remains bearish. The pair is struggling to find acceptance above $2,600 and the Relative Strength Index (RSI) in the 4-hour chart remains flat at levels below the 50 threshold, highlighting the bearish momentum. Immediate resistance is at the $2,605 intra-day high, with the key resistance area to challenge the bearish trend at the $2,625-$2,630 area (November 28, December 2 lows). On the downside, supports are at Wednesday’s low at around $2,580, ahead of November’s trough at $2,540.
OANDA:XAUUSDShort
by KingForex078
BPTH could be in for a bull market in 2025!One new low cap stock pick with my research described below, please do your own research aswell and remember these are risky moves - thus small allocation. I will be back with many crypto charts for next year as well, don't worry! Bio-Path Holdings (BPTH) Overview: Bio-Path Holdings, Inc. is a biotechnology company focused on developing nucleic acid cancer drugs using its proprietary DNAbilize antisense RNAi nanoparticle technology. This technology allows for the development of drugs that can be administered through intravenous transfusion, targeting specific genes associated with cancer. Last week, Bio-Path Holdings announced preclinical results for their drug candidate BP1001-A. The study demonstrated that BP1001-A enhances insulin sensitivity, suggesting its potential as a treatment for obesity in patients with Type 2 diabetes. In 2025, Bio-Path Holdings plans to initiate a first-in-human Phase 1 clinical trial for BP1001-A, focusing on validating its safety, measuring pharmacokinetics, and establishing dosing for potential pivotal trials. This trial is aimed at further exploring BP1001-A's potential as a treatment for obesity and related metabolic diseases in patients with Type 2 diabetes. A successful trial would likely lead to a significant increase in Bio-Path Holdings' stock price. The news of positive clinical results would be seen as a validation of the drug's potential, attracting more investor interest and possibly leading to partnerships or buyouts from larger pharmaceutical companies. SPECULATION: Estimating the yearly revenue potential and a fair valuation for Bio-Path Holdings (BPTH) based on BP1001-A's market entry involves several speculative assumptions, as we lack specific data on market penetration, pricing, competition, and long-term efficacy. Here's a theoretical breakdown: Revenue Potential: Market Size and Share: Obesity and Type 2 Diabetes Market: The global market for treatments of obesity and Type 2 diabetes is substantial. For context, the global diabetes market alone was valued at approximately $51.1 billion in 2022, expected to reach $81.6 billion by 2030, growing at a CAGR of around 6.5% (). However, BP1001-A would be competing in a segment of this market focused on novel treatments or those with a unique mechanism like insulin sensitivity enhancement. Assumed Market Share: Assuming BP1001-A captures a niche segment, let's speculate it achieves a 1% to 5% market share due to its novel mode of action and targeting a specific subset of Type 2 diabetes patients with obesity. Pricing and Usage: Drug Pricing: New diabetes drugs, especially those with innovative mechanisms, can be priced high. For instance, if we assume a yearly cost per patient of $10,000 (considering the high cost of biologics and similar therapies), Patient Population: If we estimate that 1% of the diabetic population globally (approximately 537 million adults in 2021 according to IDF) could benefit from this drug, that's about 5.37 million patients. At 5% market share, this would mean 268,500 patients. Revenue Calculation: Annual Revenue: If 268,500 patients use BP1001-A at $10,000 per year, the potential annual revenue would be approximately $2.685 billion. For a 1% market share (53,700 patients), it would be around $537 million. Valuation: DCF Approach: A Discounted Cash Flow (DCF) analysis would be the traditional method to value BPTH if BP1001-A were to generate such revenues. Here's a simplified speculative approach: Cash Flow: Assuming 50% of revenue translates into gross profit (considering R&D, marketing, and other costs), a 1% market share would yield $268.5 million in gross profit, and 5% would yield $1.3425 billion. Discount Rate: Biotech companies often have high discount rates due to risk. Let's assume a 15% discount rate for this speculative valuation. Growth & Terminal Value: Assume growth stabilizes after initial high growth years, with a terminal growth rate of 2% post-patent exclusivity period (which might be around 20 years from patent to market). Valuation Calculation: With a 1% market share scenario: Present Value of Cash Flows for first 10 years (assuming rapid growth then stabilization): $268.5M * Annuity Factor at 15% = $1.4 billion (very roughly). Terminal Value (Gordon Growth Model) = $268.5M * (1+0.02)/(0.15-0.02) = $2.14 billion. Total Equity Value = PV of cash flows + Terminal Value = $3.54 billion. With a 5% market share scenario: Present Value of Cash Flows for first 10 years: $1.3425B * Annuity Factor at 15% = $7 billion (again, very roughly). Terminal Value = $1.3425B * (1+0.02)/(0.15-0.02) = $10.7 billion. Total Equity Value = $17.7 billion. Market Multiples: If we use industry multiples (PE ratios for biotech can be very high, especially for novel treatments), with a PE ratio of 20-30 for a company with significant growth potential, the valuation based on earnings from BP1001-A alone would range from: 1% Market Share: $5.37 billion (20 * $268.5M) to $8.055 billion (30 * $268.5M). 5% Market Share: $26.85 billion (20 * $1.3425B) to $40.275 billion (30 * $1.3425B). Fair Valuation: Given these speculative numbers, a fair valuation for BPTH based solely on BP1001-A's potential would be somewhere in the middle of these ranges, adjusted for the company's current financials, other pipeline drugs, and market conditions. Considering the above, a conservative estimate might place BPTH's valuation in the range of $3 billion to $10 billion, depending on market penetration optimism, with the understanding that this is highly speculative and subject to countless variables including regulatory approval, actual market acceptance, and competitive landscape. CONCLUSION & TA: This simply means, IF(!) this drug is succesfull the market cap of this company would significantly rise. Currently we're sitting at a 5.43 million market cap (at close, so lower now), thus its a 100 to 1000x potential or it drops to zero. Last note, price needs to stay above $1 to stay compliant with Nasdaq rules or else there could be an inverse stock split 2 to 1 for example or they face delisting by the end of Q3 2025. I'm not too worried because this is the same as SEALSQ faced before it 10x'd in the last few weeks. TA wise: we're retesting previous resistance and the bull market support band. Chart has been down only for years, capitulation after capitulation thus chance of a rebound should be there. I grabbed a small allocation to sit out for 2025, if the clinical trials are successful, we'll in for a big bull market. If not succesfull, we'll likely lose our money. A very decent risk / reward ratio of you invest an amount you can afford to lose and not more than 5% of your portfolio. This is one of my low cap stock picks, next to LAES (10x since entry) and MOBX (entry last week, flat pa for now). I will be scouting for more but for now, happy holidays!
NASDAQ:BPTHLong
by cryptobullethbtcxlm
Hellena | EUR/USD (4H): Short to Support area 1.02539.Dear Colleagues, due to the recent sharp price movement, I have redrawn the waves and now I see the completion of the five-wave impulse in the wave “5” of higher order. I expect that the price should update the nearest local minimum of the wave “3” 1.03350. I expect the price to reach at least the area of 1.02539. Manage your capital correctly and competently! Only enter trades based on reliable patterns!
Short
by Hellena_Trade
3
AUD/USD Trading Plan Long/Short Swing TradeThe pair has reached a 2 years low (0.6200). There are two scenario's that I will be following. Scenario 1 Long To trigger a long entry there are a few thing I wish to see before I enter go long. 1. Break of the down slopping trend line around 0.6300 level 2. Creation of new HH and HL (New up-slopping trendline) 3. Break of the resistance level at 0.6350 4. re-test of the level or a fundamental catalyst to give the power for a strong break out 5. Cross of the EMA100 For this entry I will target the 0.6550 level and SL bellow the last HL Scenario 2 Short (Following the current down trend) the only additional confirmation I will need for a short entry is the break and re-test of 0.6200 level, also a look on the volume indicators. The level I will target is 0.6000 super old support level(4.5 years) For my Day trade position I will be using the same levels as reference, using more of chart/candle patterns on 1 and 4h hours time frames for 30-40 pips targets. I hope you enjoyed or find useful this information, feedback is always welcome. Merry Christmas and Happy New Year!
by Don_Bob
Could the Gold reverse from here?The price is reacting off the resistance level which is a pullback resistance and could reverse from this level to our take profit. Entry: 2,627.88 Why we like it: There is a pullback resistance level. Stop loss: 2,655.19 Why we like it: There is a pullback resistance level that aligns with the 50% Fibonacci retracement. Take profit: 2,585.75 Why we like it: There is a pullback support level. Enjoying your TradingView experience? Review us! Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Everest Fortune Group’). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Everest Fortune Group.
VANTAGE:XAUUSDShort
by VantageMarkets
Bearish drop?GBP/USD is reacting off the resistance level which is an overlap resistance that aligns with the 50% Fibonacci retracement and could drop from this level to our take profit. Entry: 1.2615 Why we like it: There is an overlap resistance level that aligns with the 50% Fibonacci retracement. Stop loss: 1.2725 Why we like it: There is an overlap resistance level. Take profit: 1.2486 Why we like it: There is a pullback support level. Enjoying your TradingView experience? Review us! Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Everest Fortune Group’). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Everest Fortune Group.
Short
by VantageMarkets
NIFTY : Trading Levels and Plan for 23-Dec-202423-Dec-2024 Nifty Trading Plan On last trading session prices met with the targets on breaking and sustaining below mentioned levels and met with all targets on down side. Strategies for upcoming trading session Color-Coding: Yellow: Sideways trend. Green: Bullish trend. Red: Bearish trend. 23-Dec-2024 Trading Scenarios: Gap Up Opening (+100 points): If Nifty opens above 23,953 but below 24,058 , expect initial resistance at 24,058 . Watch for rejection signals such as bearish candlestick patterns (e.g., pin bars or engulfing) to initiate short trades targeting 23,747-23,603 . However, if prices sustain above 24,058 , this zone transforms into support, indicating bullish sentiment. Enter long trades cautiously above 24,058 with targets of 24,300-24,400 . Use a stop loss at 23,950 . Flat Opening: A flat opening near 23,631-23,603 suggests the no-trade zone remains intact. Wait for a breakout above 23,747 or a breakdown below 23,603 . Above 23,747: Long trades targeting 23,953-24,058 . Below 23,603: Short trades targeting 23,281-23,194 . Use stop losses based on an hourly close for safer risk management. Gap Down Opening (-100 points or more): A gap down below 23,603 places immediate focus on the buyer’s support zone at 23,281-23,194 . Look for bullish reversal patterns (e.g., hammer or bullish engulfing) within this zone to initiate long trades. If prices break below 23,194 , bearish momentum could intensify. Short trades targeting 23,000-22,850 become viable. Maintain a stop loss above 23,281 for these positions. Risk Management Tips for Options Trading: Use defined risk strategies like buying options or limited-loss spreads. Avoid aggressive averaging when trades move against your position. Always calculate the maximum loss potential before entering trades. Exit positions if the index stays in the no-trade zone for extended periods. Summary & Conclusion: Nifty’s trading action on 23-Dec-2024 will revolve around the critical zones discussed. Respect the defined levels and avoid impulsive trades within the no-trade zone. Wait for confirmation before entering trades to maximize risk-reward ratios. Disclaimer: I am not a SEBI-registered analyst. This analysis is for educational purposes only. Please consult your financial advisor before making trading decisions.
NSE:NIFTY
by LiveTradingBox
Bitcoin (BTC): Dropped 14-15% from ATH(Possible Support Re-Test)Bitcoin is showing some signs of weakness where last week we had a full dominance of sellers taking over the ATHs zoen and price dumped around 14-15% since then. The upcoming weekly candle will be an important one as we will see who will manage to maintain this zone, whether sellers will secure this zone and lead the price back to the local support zone (which would be an ideal zone to buy everything) or buyers will try to take back the dominance and lead the price back to ATH before the end of 2024. We are looking more for that first scenario!! Swallow Team
Short
by SwallowAcademy
1
Falling towards pullback support?USD/CHF is falling towards the support level which is a pullback support that aligns with the 127.2% Fibonacci extension and also slightly above the 50% Fibonacci retracement and could bounce from this level to our take profit. Entry: 0.8888 Why we like it: There is a pullback support level that aligns with the 127.2% Fibonacci extension and also slightly above the 50% Fibonacci retracement. Stop loss: 0.8832 Why we like it: There is a pullback support level that is slightly below the 61.8% Fibonacci retracement. Take profit: 0.8960 Why we like it: There is a pullback resistance3 level that lines up with the 50% Fibonacci retracement. Enjoying your TradingView experience? Review us! Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Everest Fortune Group’). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Everest Fortune Group.
Long
by VantageMarkets
Bitcoin ready to enter the buy zone based on price+volume indi TL:DR the Bitcoin dip is over based on this indicator that showed buy signals before the big rise, and also gave us a sell signal before the most recent large dip. If this indicator continues to be correct, it seems like the crash is over and we could be waiting for another buy zone very shortly. Below is a more detailed description of the indicator I created which is typically based on simple price and volume action. I designed a new indicator that I dub the "Money Flow by NHBprod" indicator. It helps to EASILY identify potential trade opportunities without over complicating the process. In short, MFI typically uses volume and pricing data in its calculations which are 2 important keys to consider when trading. However, the actual indicator typically lags behind actual trade opportunities. I heavily modified the standard MFI so that this new indicator can be used to easily see where to buy and where to sell. It also has built in alerts which can be used to automate trading. How It Works The indicator calculates the Money Flow Index (MFI), but is heavily modified both in terms of calculations, performance, and output. The indicator computes the MFI using the closing price and a user-defined length. A linear regression moving average is applied to the MFI, smoothing out fluctuations to provide clear signals. Then we have Buy & Sell Zones which are Customizable thresholds that are used to determine when to buy and when to sell. When the moving average crosses into the buy zone, green highlights appear on the chart; similarly, red highlights appear when it enters the sell zone. Alerts: Integrated alert conditions notify traders when the moving average enters either zone, ensuring they never miss a trade opportunity. What It Does Identifies Opportunities: The indicator visually and dynamically highlights buy and sell zones directly on the pricing chart for easier decision-making. Sends Alerts: Receive real-time alerts for both buy and sell signals, so you're always in sync with the market. Simplifies Analysis: By focusing on the MFI's moving average and clearly marking significant zones, the indicator eliminates noise and simplifies market analysis. Enhanced Visualization: The green and red highlighted zones on the pricing chart offer an intuitive, at-a-glance understanding of market conditions.
Long
by nhbprod